11 Sep 2024
// PR NEWSWIRE
11 Aug 2024
// INDIANPHARMAPOST
09 Apr 2024
// PR NEWSWIRE
01 3ASENAPINE MALEATE
02 2ASPIRIN; BUTALBITAL; CAFFEINE
03 1ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE
04 1AVIBACTAM SODIUM; CEFTAZIDIME
05 2BRIMONIDINE TARTRATE
06 2CHLORAMPHENICOL
07 1CHLORAMPHENICOL; PREDNISOLONE
08 1CROMOLYN SODIUM
09 1CYCLOSPORINE
10 1DEXAMETHASONE
11 2DICYCLOMINE HYDROCHLORIDE
12 3DILTIAZEM HYDROCHLORIDE
13 1DIPIVEFRIN HYDROCHLORIDE
14 1EPINASTINE HYDROCHLORIDE
15 1ESTRADIOL
16 4ETHINYL ESTRADIOL; NORETHINDRONE
17 1ETHOXZOLAMIDE
18 1FERRIC OXYHYDROXIDE
19 4FLUOCINOLONE ACETONIDE
20 1FLUOROMETHOLONE
21 1FLUOROMETHOLONE; SULFACETAMIDE SODIUM
22 1FLURBIPROFEN SODIUM
23 1GATIFLOXACIN
24 1GENTAMICIN SULFATE
25 2GENTAMICIN SULFATE; PREDNISOLONE ACETATE
26 5HYDROCORTISONE
27 2HYDROXYPROGESTERONE CAPROATE
28 1IDOXURIDINE
29 1KETOROLAC TROMETHAMINE
30 2LEVOBUNOLOL HYDROCHLORIDE
31 6LIOTRIX (T4;T3)
32 1MEDRYSONE
33 1MEMANTINE HYDROCHLORIDE
34 12MORPHINE SULFATE
35 1NAPHAZOLINE HYDROCHLORIDE
36 4NEBIVOLOL HYDROCHLORIDE
37 1NEDOCROMIL SODIUM
38 1NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PREDNISOLONE ACETATE
39 1OFLOXACIN
40 2OXYBUTYNIN
41 5OnabotulinumtoxinA
42 1PHENYLEPHRINE HYDROCHLORIDE; PYRILAMINE MALEATE
43 1PODOFILOX
44 1POLYMYXIN B SULFATE; TRIMETHOPRIM SULFATE
45 2PREDNISOLONE ACETATE; SULFACETAMIDE SODIUM
46 2PROGESTERONE
47 1PROPARACAINE HYDROCHLORIDE
48 1SELENIUM SULFIDE
49 2SILODOSIN
50 3SULFACETAMIDE SODIUM
51 5TAZAROTENE
52 2TRETINOIN
53 1TRIAMCINOLONE ACETONIDE
54 3TRIMEPRAZINE TARTRATE
55 2TROSPIUM CHLORIDE
56 2URSODIOL
01 2AEROSOL;TOPICAL
02 17CAPSULE, EXTENDED RELEASE;ORAL
03 5CAPSULE;ORAL
04 7CREAM;TOPICAL
05 1CREAM;VAGINAL
06 1EMULSION; OPHTHALMIC
07 1FILM, EXTENDED RELEASE;TRANSDERMAL
08 1GEL, METERED;TRANSDERMAL
09 5GEL;TOPICAL
10 2GEL;VAGINAL
11 3INJECTABLE;INJECTION
12 1INJECTABLE;INTRA-ARTICULAR, INTRAMUSCULAR, INTRAVITREAL
13 1LOTION/SHAMPOO;TOPICAL
14 6OINTMENT;OPHTHALMIC
15 2OINTMENT;TOPICAL
16 1POWDER;INTRAVENOUS
17 21SOLUTION/DROPS;OPHTHALMIC
18 1SOLUTION;ORAL
19 2SOLUTION;TOPICAL
20 3SUSPENSION/DROPS;OPHTHALMIC
21 2SUSPENSION;OPHTHALMIC
22 1SYRUP;ORAL
23 17TABLET;ORAL
24 2TABLET;ORAL-21
25 2TABLET;ORAL-28
26 3TABLET;SUBLINGUAL
27 5VIAL; SINGLE-USE
01 20.01%
02 10.01% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
03 10.0125MG;0.0031MG
04 30.025%
05 10.025MG;0.0063MG
06 10.03% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
07 20.035MG;0.5MG
08 20.035MG;1MG
09 10.0375%
10 30.05%
11 10.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
12 10.05MG;0.0125MG
13 10.075%
14 60.1%
15 10.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
16 10.1%;10%
17 10.12%;0.1%
18 10.15MG;0.0375MG
19 10.1MG;0.025MG
20 10.2% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
21 20.2%;10%
22 10.25% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
23 10.25MG;0.0625MG
24 20.3%
25 60.5%
26 10.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
27 51%
28 11%;0.5%
29 210%
30 110,000 UNITS/ML;EQ 1MG BASE/ML
31 2100 UNITS/VIAL
32 1100MG
33 110MG
34 110MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
35 1120MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
36 1125MG
37 1125MG/ML
38 1130MG
39 1150MG
40 1180MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
41 12% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
42 22.5%
43 1200 UNITS/VIAL
44 1200MG
45 120MG
46 220MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
47 1240MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
48 1250MG
49 1250MG/ML
50 12MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
51 13%
52 13.9MG/24HR
53 130%
54 130MG
55 2325MG;50MG;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
56 1325MG;50MG;40MG;30MG
57 14%
58 14% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
59 140MG
60 14MG
61 250 UNITS/VIAL
62 1500MG
63 150MG
64 160MG
65 160MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
66 170MG
67 18%
68 180MG
69 18MG
70 18MG/0.1ML (8MG/0.1ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
71 1EQ 0.3% BASE
72 1EQ 0.3% BASE;0.6%
73 1EQ 0.3% BASE;1%
74 1EQ 0.35% BASE;10,000 UNITS/ML;0.5%
75 1EQ 0.5GM BASE;2GM/VIAL
76 1EQ 100MG IRON/2ML (EQ 50MG IRON/ML)
77 2EQ 10MG BASE
78 3EQ 2.5MG BASE
79 1EQ 2.5MG BASE/5ML
80 1EQ 20MG BASE
81 3EQ 5MG BASE
01 84DISCN
02 25RX
03 6Blank
RLD : Yes
TE Code : AB
Dosage Form : TABLET; SUBLINGUAL
Proprietary Name : SAPHRIS
Dosage Strength : EQ 5MG BASE
Approval Date : 2009-08-13
Application Number : 22117
RX/OTC/DISCN : RX
RLD : Yes
TE Code : AB
RLD : Yes
TE Code : AB
Dosage Form : TABLET; SUBLINGUAL
Proprietary Name : SAPHRIS
Dosage Strength : EQ 10MG BASE
Approval Date : 2009-08-13
Application Number : 22117
RX/OTC/DISCN : RX
RLD : Yes
TE Code : AB
RLD : Yes
TE Code : AB
Dosage Form : TABLET; SUBLINGUAL
Proprietary Name : SAPHRIS
Dosage Strength : EQ 2.5MG BASE
Approval Date : 2015-03-12
Application Number : 22117
RX/OTC/DISCN : RX
RLD : Yes
TE Code : AB
RLD : Yes
TE Code :
Dosage Form : TABLET; ORAL
Proprietary Name : FIORINAL
Dosage Strength : 325MG;50MG;40MG **Federa...
Approval Date : 1986-04-16
Application Number : 17534
RX/OTC/DISCN : DISCN
RLD : Yes
TE Code :
RLD : Yes
TE Code :
Dosage Form : CAPSULE; ORAL
Proprietary Name : FIORINAL
Dosage Strength : 325MG;50MG;40MG **Federa...
Approval Date : 1986-04-16
Application Number : 17534
RX/OTC/DISCN : DISCN
RLD : Yes
TE Code :
RLD : Yes
TE Code :
ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE
Dosage Form : CAPSULE; ORAL
Proprietary Name : FIORINAL W/CODEINE
Dosage Strength : 325MG;50MG;40MG;30MG
Approval Date : 1990-10-26
Application Number : 19429
RX/OTC/DISCN : DISCN
RLD : Yes
TE Code :
RLD : Yes
TE Code :
Dosage Form : POWDER; INTRAVENOUS
Proprietary Name : AVYCAZ
Dosage Strength : EQ 0.5GM BASE;2GM/VIAL
Approval Date : 2015-02-25
Application Number : 206494
RX/OTC/DISCN : RX
RLD : Yes
TE Code :
RLD : No
TE Code :
Dosage Form : SOLUTION/DROPS; OPHTHALMIC
Proprietary Name : ALPHAGAN
Dosage Strength : 0.5%
Approval Date : 1997-03-13
Application Number : 20490
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : Yes
TE Code :
Dosage Form : SOLUTION/DROPS; OPHTHALMIC
Proprietary Name : ALPHAGAN
Dosage Strength : 0.2% **Federal Register ...
Approval Date : 1996-09-06
Application Number : 20613
RX/OTC/DISCN : DISCN
RLD : Yes
TE Code :
RLD : No
TE Code :
Dosage Form : SOLUTION/DROPS; OPHTHALMIC
Proprietary Name : CHLOROPTIC
Dosage Strength : 0.5%
Approval Date : 1982-01-01
Application Number : 50091
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
LOOKING FOR A SUPPLIER?